RU94007090A - Глазная линза - Google Patents

Глазная линза

Info

Publication number
RU94007090A
RU94007090A RU94007090/25A RU94007090A RU94007090A RU 94007090 A RU94007090 A RU 94007090A RU 94007090/25 A RU94007090/25 A RU 94007090/25A RU 94007090 A RU94007090 A RU 94007090A RU 94007090 A RU94007090 A RU 94007090A
Authority
RU
Russia
Prior art keywords
lens
ester
aliphatic alcohol
toxins
keratitis
Prior art date
Application number
RU94007090/25A
Other languages
English (en)
Inventor
Дж.Вандерлаан Дуглас
Us]
К.Браун-Скробот Сьюзан
Л.Шульц Клайд
Original Assignee
Джонсон энд Джонсон Вижн Продактс
Джонсон энд Джонсон вижн Продактс, Инк.
Инк. (US)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джонсон энд Джонсон Вижн Продактс, Джонсон энд Джонсон вижн Продактс, Инк., Инк. (US) filed Critical Джонсон энд Джонсон Вижн Продактс
Publication of RU94007090A publication Critical patent/RU94007090A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Eyeglasses (AREA)
  • Medicinal Preparation (AREA)
  • Optical Filters (AREA)
  • Prostheses (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

Приводится глазная линза, предназначенная для размещения на внешней поверхности глаза. Линза пропитана сложным эфиром многоатомного алифатического спирта и жирной кислоты или содержит его на своей поверхности, при этом фрагмент, образованный алифатическим спиртом, имеет по крайней мере одну гидроксильную группу. Сложный эфир присутствует в количестве, необходимом и достаточном для предотвращения или ослабления выделения бактериальных токсинов в том случае, когда линза подвергается действию указанных токсинов. Линза наиболее приспособлена для мягких контактных линз на основе гидрогеля и обладает преимуществом при устранении, снижении вероятности возникновения и предотвращении кератита. Бактериальный кератит является инфекцией на роговой оболочке глаза, которая может возникнуть при длительном ношении линзы и вызвать поражение роговой оболочки.

Claims (1)

  1. Приводится глазная линза, предназначенная для размещения на внешней поверхности глаза. Линза пропитана сложным эфиром многоатомного алифатического спирта и жирной кислоты или содержит его на своей поверхности, при этом фрагмент, образованный алифатическим спиртом, имеет по крайней мере одну гидроксильную группу. Сложный эфир присутствует в количестве, необходимом и достаточном для предотвращения или ослабления выделения бактериальных токсинов в том случае, когда линза подвергается действию указанных токсинов. Линза наиболее приспособлена для мягких контактных линз на основе гидрогеля и обладает преимуществом при устранении, снижении вероятности возникновения и предотвращении кератита. Бактериальный кератит является инфекцией на роговой оболочке глаза, которая может возникнуть при длительном ношении линзы и вызвать поражение роговой оболочки.
RU94007090/25A 1993-03-02 1994-03-02 Глазная линза RU94007090A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25,018 1993-03-02
US08/025,018 US5472703A (en) 1993-03-02 1993-03-02 Ophthalmic lens with anti-toxin agent

Publications (1)

Publication Number Publication Date
RU94007090A true RU94007090A (ru) 1996-08-20

Family

ID=21823602

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94007090/25A RU94007090A (ru) 1993-03-02 1994-03-02 Глазная линза

Country Status (25)

Country Link
US (1) US5472703A (ru)
EP (1) EP0613694B1 (ru)
JP (1) JP3390999B2 (ru)
KR (1) KR940021079A (ru)
CN (1) CN1099605C (ru)
AT (1) ATE171077T1 (ru)
AU (1) AU675101B2 (ru)
BR (1) BR9400787A (ru)
CA (1) CA2116834A1 (ru)
CZ (1) CZ46194A3 (ru)
DE (1) DE69413271T2 (ru)
ES (1) ES2122163T3 (ru)
FI (1) FI940976A (ru)
GR (1) GR1002257B (ru)
GT (1) GT199400014A (ru)
HU (1) HU214060B (ru)
IL (1) IL108820A (ru)
NO (1) NO940707L (ru)
NZ (1) NZ260004A (ru)
PH (1) PH31000A (ru)
RU (1) RU94007090A (ru)
SG (1) SG63541A1 (ru)
TW (1) TW289094B (ru)
UY (1) UY23735A1 (ru)
ZA (1) ZA941430B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2465920C2 (ru) * 2006-10-31 2012-11-10 Джонсон Энд Джонсон Вижн Кэа, Инк. Кислотные способы получения антибактериальных контактных линз

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69629230D1 (de) * 1995-03-24 2003-09-04 Ocular Res Of Bonton Inc Hydrogellinse mit Lipid-Vorbeschichtigung
US5554187A (en) * 1995-08-18 1996-09-10 Rizzo, Iii; Joseph Medication dispensing intra-ocular lens system
CA2198972A1 (en) * 1996-03-05 1997-09-05 Clyde L. Schultz Contact lens containing a leachable absorbed antibody
US6592814B2 (en) 1998-10-02 2003-07-15 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
US20070104798A1 (en) * 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
FR2804868B1 (fr) * 2000-02-15 2003-03-07 Oreal Utilisation de composes permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
FR2804865B1 (fr) * 2000-02-15 2003-11-28 Oreal Utilisation des corps gras particuliers permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
MXPA03003542A (es) * 2000-10-24 2004-08-12 Bausch & Lomb Prevencion de la union bacterial a biomateriales mediante polisacaridos cationicos.
US7402318B2 (en) 2001-11-14 2008-07-22 Novartis Ag Medical devices having antimicrobial coatings thereon
IL164822A0 (en) * 2002-04-25 2005-12-18 Rapidheal Inc Growth factor delivery system for the healing of wounds and the prevention and disease
US20030203032A1 (en) * 2002-04-25 2003-10-30 Schultz Clyde L. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
US7282214B2 (en) * 2002-12-19 2007-10-16 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
US20050074497A1 (en) * 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US9216106B2 (en) 2003-04-09 2015-12-22 Directcontact Llc Device and method for the delivery of drugs for the treatment of posterior segment disease
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US20100120013A1 (en) * 2008-11-07 2010-05-13 Mb Research Laboratories, Inc. Procedure for long term corneal culture
US8865685B2 (en) 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
US8974055B2 (en) 2013-03-15 2015-03-10 Johnson & Johnson Vision Care, Inc. Method and apparatus for encapsulating a rigid insert in a contact lens for correcting vision in astigmatic patients
WO2016178151A1 (en) 2015-05-04 2016-11-10 Ecole Polytechnique Federale De Lausanne (Epfl) Ophthalmic contact lens with a compressible affinity matrix
CN105410365B (zh) * 2015-12-17 2019-06-11 浙江大学 一种可替代抗生素的饲料添加剂及其应用
KR20210093609A (ko) 2020-01-20 2021-07-28 이원계 승용차의 창을 통해 내부로 유입되는 공기배출시스템
KR20220152722A (ko) 2021-05-10 2022-11-17 이원계 주행 중 승용차의 측면창을 통해 내부로 유입되는 공기배출시스템

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485029A (en) * 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
US4931279A (en) * 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
JPH01206312A (ja) * 1988-02-15 1989-08-18 Kao Corp コンタクトレンズ洗浄剤
US4921279A (en) * 1988-08-18 1990-05-01 Ncr Corporation MICR printing technique and apparatus to minimize rejects with correction stickers
ZM1990A1 (en) * 1989-04-27 1991-06-28 Mcneil Ppc Inc Additives to tampons

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2465920C2 (ru) * 2006-10-31 2012-11-10 Джонсон Энд Джонсон Вижн Кэа, Инк. Кислотные способы получения антибактериальных контактных линз

Also Published As

Publication number Publication date
IL108820A0 (en) 1994-06-24
EP0613694B1 (en) 1998-09-16
ATE171077T1 (de) 1998-10-15
US5472703A (en) 1995-12-05
TW289094B (ru) 1996-10-21
CN1101722A (zh) 1995-04-19
GT199400014A (es) 1995-08-23
PH31000A (en) 1997-12-23
BR9400787A (pt) 1994-11-22
FI940976A0 (fi) 1994-03-01
EP0613694A1 (en) 1994-09-07
IL108820A (en) 1997-02-18
CZ46194A3 (en) 1994-10-19
AU5649394A (en) 1994-09-08
NZ260004A (en) 1995-12-21
NO940707L (no) 1994-09-05
HUT67519A (en) 1995-04-28
NO940707D0 (no) 1994-03-01
SG63541A1 (en) 1999-03-30
ES2122163T3 (es) 1998-12-16
JP3390999B2 (ja) 2003-03-31
JPH06343686A (ja) 1994-12-20
UY23735A1 (es) 1994-06-16
AU675101B2 (en) 1997-01-23
CN1099605C (zh) 2003-01-22
HU9400618D0 (en) 1994-05-30
GR1002257B (en) 1996-04-23
CA2116834A1 (en) 1994-09-03
HU214060B (en) 1997-12-29
ZA941430B (en) 1995-09-01
KR940021079A (ko) 1994-10-17
DE69413271D1 (de) 1998-10-22
FI940976A (fi) 1994-09-03
DE69413271T2 (de) 1999-04-08

Similar Documents

Publication Publication Date Title
RU94007090A (ru) Глазная линза
US4259202A (en) Cleaning and preservative solution for contact lenses
CA2361827A1 (en) Multifocal ophthalmic lens with reduced halo size
ES2083030T3 (es) Metodo de tratamiento de la inflamacion ocular.
DE3890892D2 (en) Spectacle lens with astigmatic effect
EP0420598A3 (en) Contact lens based on a hydrophilic gel
Stern Pseudomonas keratitis and contact lens wear: the lens/eye is at fault
Bignell Infection of the cornea with B. pyocyaneus: Clinical study and summary of ten cases personally observed
GB2305256A (en) Photochromic or polarising contact lens
PL345544A1 (en) Oxazolidinones to treat eye infections
KAUFMAN et al. Therapeutic soft bandage lenses
AU3581695A (en) Method and means for prevention and treatment of secondary cataract
Procope Delayed-onsetPseudomonaskeratitis after radial keratotomy
Singh et al. Actinomycetic corneal ulcer
Lawrence et al. Effect of contact lenses on Pseudomonas ulcers in rabbit corneas
Jain et al. Metastatic endophthalmitis in a patient with major burns: a rare complication
Woodward Therapeutic silicone rubber lenses
CN88210330U (zh) 手术防护眼罩
RU94009114A (ru) Очки для лечения ранений и повреждений роговицы глаза
JL Infection of the cornea with B. pyocyaneus. Clinical study and summary of ten cases personally observed.
Beehler Ocular onchocerciasis in Central Amer-ica, Africa and the British Isles. Choyce, D., Trans. roy. Sot. trop. Med. Hyg. 58: 11, Jan., 1964. The occurrence, appearance and course
RU93043496A (ru) Средство антиоксидантной защиты сред и тканей глаза
Mehta et al. Therapeutic applications of hydrophilic soft contact lenses
Hobden et al. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.
汪磊 et al. HEARING SHIFT AND INNER EAR PATHOLOGY OF GUINEA PIGS EXPOSED TO OCTAVE BANDS OF NOICE CENTERED AT 63 Hz AND 4kHz